The Calmer Co Moves Closer to Profitability with Record Quarterly Revenue and Strong Sales Growth
The Calmer Co (ASX: CCO) has reported record global revenue of $2.4 million for the September 2026 quarter, a 26% increase on the previous quarter as strong sales growth across Australia and the US drove the company closer to breakeven.
The company said the result reflected accelerating momentum in both retail and wholesale markets, supported by strong demand from Coles and Woolworths in Australia and growing consumer adoption of kava-based wellness products in the US.
Founder and chief executive officer Mr Zane Yoshida said the quarter marked a key step toward profitability as operational efficiencies continued to improve.
Sales Momentum Across All Channels
Australian revenue rose 30% to $1.4m, underpinned by sustained order growth from Coles and Woolworths, while a 68% rise in retail sales to $1.15m accounted for almost half of group revenue.
US sales increased 21% to $936,000, driven by a full quarter of expanded product listings, targeted online promotions and rising subscription orders through Amazon.
Growth in the B2B segment also contributed, with strong repeat orders for CO₂ extract and flavoured kava shots.
Wholesale sales rose 30% to a new record of $314,000, representing 13% of total revenue, with the company citing continued traction with IMCD Network Nutrition and several new resellers as key contributors.
Cash Use Improves as Scale Efficiencies Build
Net cash used in operations fell 39% to $597,000, reflecting improved operating discipline and reduced costs despite ongoing US market investment, and the company ended the quarter with $1.37m in cash and $2m in inventory.
The first $700,000 tranche of a $1.4m convertible note facility that is helping build wholesale stock and support new product rollouts supported funding.
Management said the reduced cash burn demonstrates the scalability of its business model and continued progress toward breakeven.
The Calmer Co sees its vertically integrated supply chain and expanding retail partnerships providing a strong foundation for further growth across its key markets, and plans to continue leveraging its innovation pipeline and brand strength to meet rising global demand for kava-based functional products.
“Kava continues to gain strong global momentum as a leading functional ingredient, with demand accelerating across key markets,” Mr Yoshida said, adding that consumer acceptance is growing rapidly.